Communiqués electroCore, Inc. Deutsche Boerse AG

Actions

43E0

US28531P2020

Equipement, fournitures et distribution médicale

Marché Fermé - Deutsche Boerse AG 21:42:37 18/09/2026			Varia. 5j.	Varia. 1 janv.
9,650 ^EUR	+1,05%		+16,97%	+152,62%

09/09	ElectroCore, Inc. annonce la nomination de co-directeurs généraux, effective au 8 septembre 2026	CI
09/09	ElectroCore, Inc. annonce des nominations au sein de son conseil d'administration, effectives au 8 septembre 2026	CI

Communiqués

10/09	ElectroCore to Participate at H.C. Wainwright Global Investment Conference	AQ
09/09	ElectroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers	AQ
25/08	ElectroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards	AQ
06/08	ElectroCore Announces Second Quarter 2026 Financial Results	AQ
03/08	ElectroCore to Participate in Upcoming Investor Conferences	AQ
30/07	ElectroCore to Announce Second Quarter June 30, 2026, Financial Results on Thursday, August 6, 2026	AQ
16/07	New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation	AQ
17/06	ElectroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference	AQ
09/06	Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery	AQ
02/06	ElectroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub	AQ
13/05	ElectroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia	AQ
09/05	ElectroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026	AQ
06/05	ElectroCore Announces First Quarter 2026 Financial Results	AQ
30/04	ElectroCore TAC-STIM™ Named National Semifinalist in National Safety Council Work to Zero Challenge	AQ
29/04	ElectroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026	AQ
28/04	ElectroCore to Present at the Market Movers Investor Summit on May 5, 2026	AQ
23/04	ElectroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation	AQ
08/04	ElectroCore to Participate in the 25th Annual Needham Virtual Healthcare Conference	AQ
07/04	ElectroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD	AQ
01/04	ElectroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD	AQ
31/03	ElectroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	AQ
30/03	ElectroCore Expands Intellectual Property Portfolio	AQ
19/03	ElectroCore Announces Full Year 2025 Financial Results and Organizational Changes	AQ
10/03	ElectroCore to Participate at the 38th Annual Roth Conference	AQ
09/03	ElectroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026	AQ